Jacobs Levy Equity Management’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-17,660
| Closed | -$81K | – | 1125 |
|
|
2018
Q2 | $81K | Sell |
17,660
-4,154
| -19% | -$19.1K | ﹤0.01% | 1001 |
|
|
2018
Q1 | $157K | Hold |
21,814
| – | – | ﹤0.01% | 951 |
|
|
2017
Q4 | $156K | Sell |
21,814
-1,045
| -5% | -$7.47K | ﹤0.01% | 929 |
|
|
2017
Q3 | $190K | Buy |
22,859
+3,965
| +21% | +$33K | ﹤0.01% | 874 |
|
|
2017
Q2 | $193K | Buy |
18,894
+12,144
| +180% | +$124K | ﹤0.01% | 849 |
|
|
2017
Q1 | $78K | Sell |
6,750
-2,130
| -24% | -$24.6K | ﹤0.01% | 873 |
|
|
2016
Q4 | $113K | Buy |
+8,880
| New | +$113K | ﹤0.01% | 892 |
|
|
2016
Q3 | – | Sell |
-5,385
| Closed | -$57K | – | 1200 |
|
|
2016
Q2 | $57K | Buy |
5,385
+3,130
| +139% | +$33.1K | ﹤0.01% | 1123 |
|
|
2016
Q1 | $43K | Buy |
+2,255
| New | +$43K | ﹤0.01% | 1071 |
|